Clear Labs is a private genomics testing company that conducts high-throughput DNA sequencing tests to determine if food samples contain the genetic materials of specific pathogens.
Clear Labs is the only automated and intelligent diagnostic NGS platform. The company help its customers capitalize on a new era of technology by seamlessly integrating DNA sequencing, bioinformatics, and robotics.
Clear Labs was founded in 2014 by Mahni Ghorashi and Sasan Amini. The company is headquartered in San Carlos, California.
Clear Labs’ platform leverages the latest technology in molecular testing, proprietary bioinformatics software, and robotics. It also includes an unprecedented level of automation and robotics to reduce human labor and errors.
Clear Labs’ AI and machine learning provide additional insights and trends, allowing researchers, epidemiologists and clinical labs to track infection clusters, drive intervention, and monitor the evolution of viral genes that are therapeutic targets.
Clear Labs is backed by Redmile Group, Tyson Ventures, ing VC, Menlo Ventures, Tyson Ventures, Khosla Ventures, GV and others. The company raised $18M in a new round of funding on May 14, 2020. This brings Clear Labs' total funding to $63.5M to date.